Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Adeolu Oluremi's research focuses on the development of ionic nanomedicines for cancer therapy. Their work involves creating near-infrared-responsive nanomedicines that utilize macrocyclic histone deacetylase inhibitors to enhance treatment efficacy. This approach aims to improve drug delivery and therapeutic outcomes in cancer patients.
Oluremi collaborates with researchers at the University of Arkansas at Little Rock, including Nawab Ali, Monowar Hossain, and Shahedur Rahman, as well as Mahfuzul Hassan from Philander Smith College. Their shared publications indicate a collaborative effort in advancing cancer treatment methodologies.
Metrics
- h-index: 10
- Publications: 49
- Citations: 344
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
-
Dichloroacetic Acid Enhances Photodynamic Therapy-Induced Regulated Cell Death in PANC-1 Pancreatic Cancer Cell Line (2025)
-
95 Targeting Multiple Cancer Hallmarks with Rapamycin-Loaded Gold Nanoparticles—GE11 Peptide Conjugate: A Proteomic Analysis of Pathway Suppression and Cell Death Induction (2025)
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
-
Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells (2024)
-
Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth (2023)
Collaboration Network
Top Collaborators
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Dichloroacetic Acid Enhances Photodynamic Therapy-Induced Regulated Cell Death in PANC-1 Pancreatic Cancer Cell Line
- 95 Targeting Multiple Cancer Hallmarks with Rapamycin-Loaded Gold Nanoparticles—GE11 Peptide Conjugate: A Proteomic Analysis of Pathway Suppression and Cell Death Induction
Showing 5 of 6 shared publications
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth
- Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells
- Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells
- Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Similar Researchers
Based on overlapping research topics